Sprinkle study in IR formulation [Regulatives / Guidelines]

posted by Compliance – India, 2014-03-19 06:12 (4481 d 20:06 ago) – Posting: # 12660
Views: 4,212

Dear All,

As per the draft guidance on PK study (US FDA) sprinkle study is suggested for modified release formulation. Now my question is what to do if the label of IR formulation suggest to do the sprinkle study which is not cover in draft guidance. (I am going to conduct study of Celecoxib 400 mg and RLD is Celebrex).

Regards,

Compliance

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
135 visitors (0 registered, 135 guests [including 14 identified bots]).
Forum time: 03:18 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5